Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,227,763
-$14,264 QoQ
Shares Held
60,561
+2.7% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 239 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
0
PutValue
$11,858
PutShares
147
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. NKTR ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NKTR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,227,763 | 60,561 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,242,027 | 58,958 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,103,168 | 26,092 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $1,745,775 | 67,561 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $85,830 | 126,223 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $192,757 | 207,267 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $283,741 | 218,263 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $225,723 | 182,036 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,288 | 42,246 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $89,799 | 160,357 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $148,079 | 246,800 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $104,027 | 179,360 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $180,304 | 257,579 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $445,828 | 197,270 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,199,253 | 374,767 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,231,955 | 324,199 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $346,322 | 64,253 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $11,858 | 2,200 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $1,655,285 | 122,523 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,129,959 | 174,274 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,245,899 | 130,880 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,247,480 | 112,374 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,786,411 | 105,083 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,865,029 | 112,419 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,507,904 | 151,464 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,370,613 | 188,830 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||